Xact Bio, Inc. raised $10.0M in its first filing
Xact Bio, Inc. reported its first sale of $10.0M in September 2026. This biotechnology company was incorporated in 2024 in Massachusetts. The filing lists the amount as an estimated Series A round.
The first sale occurred on September 11, 2026, and the company filed the notice on September 28, 2026. The latest filing names Eric Green and Uciane Scarlett as executive officers and directors. Chengjung Lai and Jian Shao are also listed as directors.
We do not track its open roles yet.
Every Form D filing
| First sale | Amount sold | Est. round |
|---|---|---|
| 2026-09-11 | $10.0M | Series A |
Named in the latest filing
- Eric Green
- Uciane Scarlett
- Chengjung Lai
- Jian Shao
From SEC Form D filings. Rounds are our estimate from the amount sold; filings carry no valuation. All filings on SEC EDGAR